anmelden
NYSE International 100
11.223,99
PKT
+100,89
PKT
+0,91
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.06.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.06.26 | GSK Buy | Jefferies & Company Inc. | |
| 03.06.26 | Rio Tinto Underperform | RBC Capital Markets | |
| 02.06.26 | Eni Sector Perform | RBC Capital Markets | |
| 02.06.26 | Unilever Outperform | Bernstein Research | |
| 02.06.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 02.06.26 | GSK Hold | Deutsche Bank AG | |
| 02.06.26 | Rio Tinto Hold | Deutsche Bank AG | |
| 02.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.26 | Mercedes-Benz Group (ex Daimler) Overweight | JP Morgan Chase & Co. | |
| 02.06.26 | Deutsche Telekom Buy | UBS AG | |
| 01.06.26 | AstraZeneca Overweight | Barclays Capital | |
| 01.06.26 | National Grid Sell | UBS AG | |
| 01.06.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.05.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.05.26 | National Grid Sector Perform | RBC Capital Markets | |
| 29.05.26 | Rio Tinto Kaufen | DZ BANK | |
| 29.05.26 | GSK Neutral | UBS AG | |
| 28.05.26 | GSK Buy | Jefferies & Company Inc. | |
| 28.05.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.05.26 | Sanofi Buy | Deutsche Bank AG | |
| 28.05.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.05.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 27.05.26 | GSK Buy | Jefferies & Company Inc. | |
| 27.05.26 | Novartis Buy | Deutsche Bank AG | |
| 27.05.26 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 27.05.26 | ING Group Hold | Jefferies & Company Inc. | |
| 26.05.26 | Diageo Outperform | RBC Capital Markets | |
| 26.05.26 | BP Hold | Jefferies & Company Inc. | |
| 26.05.26 | UBS Outperform | RBC Capital Markets | |
| 26.05.26 | BP Overweight | Barclays Capital | |
| 26.05.26 | BP Outperform | RBC Capital Markets | |
| 26.05.26 | GSK Underweight | Barclays Capital | |
| 26.05.26 | AXA Overweight | Barclays Capital | |
| 26.05.26 | Allianz Underweight | Barclays Capital | |
| 26.05.26 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 22.05.26 | Unilever Outperform | Bernstein Research | |
| 22.05.26 | HSBC Neutral | JP Morgan Chase & Co. | |
| 22.05.26 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. |
